Michigan Medicine and three other medical centers receive $7 million for COVID-19 outpatient convalescent plasma therapy trial
A team co-led by Michigan Medicine researchers has received funding to study the role of convalescent plasma in mitigating symptoms of COVID-19 in patients with mild illness and preventing the progression of the disease from mild to severe.